SlideShare a Scribd company logo
1 of 48
Hepatitis Viruses- A & E
Dr.Suprakash Das
Assist. Prof.
INTRODUCTION
What Viral Hepatitis is?
 Viral hepatitis is an infection that predominantly affects the liver but may also have
systemic clinical manifestations.
 The vast majority of cases of hepatitis are caused by one of five hepatotropic viruses:
Hepatitis A virus (HAV);
Hepatitis B virus (HBV);
Hepatitis C virus (HCV);
Hepatitis D (delta) virus (HDV); and
Hepatitis E virus (HEV).
 HBV, HCV, and HDV Chronic hepatitis,
 HAV Acute Hepatitis.
 HEV causes acute hepatitis in normal hosts but can cause protracted and chronic hepatitis
in immunosuppressed patients.
INTRODUCTION
What Viral Hepatitis is?
 Liver involvement may also be seen on occasion as part of systemic
infections with
Herpes simplex virus,
Epstein-Barr virus (EBV),
Varicella-zoster virus,
Enteroviruses,
Adenoviruses,
Yellow fever virus,
Mumps, rubella, and rubeola,
 but these viruses do not cause infections that primarily affect the liver.
INTRODUCTION
What Viral Hepatitis is?
 The acute clinical illnesses caused by the five hepatitis viruses (A–E)
range from asymptomatic to fulminant and fatal.
 The chronic infections caused by HBV, HCV, and HDV range from
Subclinical persistent infections to
Rapidly progressive chronic liver disease with cirrhosis and
Increased risk for hepatocellular carcinoma (HCC).
 HEV can also cause protracted and chronic infections in
immunosuppressed patients.
Acute viral hepatitis
Clinical Manifestations
 The clinical manifestations of acute viral hepatitis are similar among the five hepatitis
viruses.
 No clinical features distinguish unequivocally one from the others,
 Asymptomatic infections with the hepatitis viruses are approximately 10 to 30 times more
common than symptomatic ones.
 The incubation periods of hepatitis vary with the individual virus.
 “flulike” illness (25% Patients). Symptoms include
Malaise,
Fatigue,
Myalgia, arthralgia, and
Headache.
Anorexia, nausea, and vomiting may occur, sometimes associated with alterations in
olfaction and taste.
Acute viral hepatitis
Clinical Manifestations
 Pharyngitis, coryza, and cough may also be present.
 Low-grade fever is common and more frequent in hepatitis A and E.
 Dark urine and clay-colored stools may appear, usually 1 to 5 days before the
onset of icterus,
 A substantial portion of patients never become jaundiced.
 With the onset of jaundice, the constitutional symptoms generally abate but may
continue during the entire icteric period.
 Right upper quadrant tenderness and discomfort are present as the liver
enlarges, and
 In some patients a cholestatic clinical picture may develop, suggesting
extrahepatic biliary obstruction.
 Splenomegaly and cervical lymphadenopathy are seen in 10% to 20% of
patients.
Acute viral hepatitis
Clinical Manifestations
 As patients recover, constitutional symptoms resolve, but usually some
liver enlargement persists, as do elevations of liver biochemical tests.
 The duration of the posticteric phase is variable and ranges from 2 to 12
weeks.
 It is usually more prolonged in hepatitis B and C.
 Complete resolution of clinical and laboratory abnormalities is to be
expected 1 to 2 months after the onset of jaundice in acute hepatitis A.
 3 to 4 months after the onset of jaundice in 75% of cases of uncomplicated
acute hepatitis B or C.
 In hepatitis E, acute cases are similar to those in hepatitis A
 Protracted infection in hepatitis E Immunosuppressed patients, and
severe and fatal infection can occur in pregnant women
Acute viral hepatitis
Laboratory Features
 Serum aspartate aminotransferase (AST) and the alanine aminotransferase (ALT) activities increase to
variable levels during the prodromal phase of acute hepatitis and precede elevations in bilirubin.
 The magnitude of AST and ALT elevations do not correlate closely with the extent of liver damage.
 Peak levels vary from 400 to 4000 international units (IU)/L, and maximums are usually reached when the
patient becomes icteric.
 Jaundice Billirubin 5 to 20 mg/dL and is usually equally divided between conjugated and unconjugated
fractions.
 Neutropenia and lymphopenia may be present initially, followed by lymphocytosis with atypical
lymphocytes.
 A diffuse but modest elevation of the serum globulin fraction is often present, and antibodies to smooth
muscle and to other cell constituents can be seen.
 Prothrombin times prolonged value may indicate
 Severe hepatic synthetic defect,
 Severe hepatocellular necrosis
 Poor prognosis.
Fulminant Hepatitis
 Fulminant hepatitis is defined as severe liver failure developing within 8 weeks of the onset
of symptoms and is the most feared complication of acute hepatitis.
 It is seen primarily with hepatitis B and D
 Hepatitis A infection older patients/ chronic hepatitis B or C infection.
 Hepatitis B infection of patients with underlying chronic hepatitis C.
 Fulminant hepatitis is hardly ever seen in patients with hepatitis C alone.
 Hepatitis E may lead to acute liver failure uncommonly in men and in up to 20% of pregnant
women.
 Hepatitis E is the leading cause in India, and hepatitis B is the leading cause in France and
Japan.
 Patients with acute fulminant hepatitis usually present with hepatic encephalopathy, which may
evolve into a deep coma.
 Liver size is reduced,
 Bilirubin rises,
Fulminant Hepatitis
 Prothrombin time is markedly prolonged
 Aminotransferase levels drop.
 Ascites and peripheral edema are present, consistent with hepatic failure.
 Cerebral edema is common, and
 Brainstem compression may occur.
 Gastrointestinal bleeding, sepsis
 Respiratory failure.
 Cardiovascular collapse and renal failure are terminal events.
 The mortality rate is high (>80% in patients with deep coma), but those who
survive have a complete clinical and laboratory recovery.
 Liver transplantation, if it can be performed in time, may be lifesaving in such
patients.
Complications of Acute Hepatitis
 Uncommonly, hepatitis A Relapsing hepatitis, occurring weeks to months after
apparent recovery from hepatitis A Protracted cholestatic hepatitis persist for up
to a year.
 During the prodromal phase of hepatitis B, a serum sickness–like syndrome may
develop, characterized by arthritis or arthralgias, rash, angioedema, and,
rarely, hematuria and proteinuria.
 Essential mixed cryoglobulinemia (EMC) and associated lymphoproliferative
disorders can complicate chronic (not acute) hepatitis C.
 Hepatitis C may be associated with abnormalities in lipoprotein and glucose
metabolism.
 The risk of chronic infection after acute hepatitis B in otherwise healthy adults is
appropriately 1%, whereas the corresponding risk of chronicity after acute
hepatitis C is 85% to 90%.
 Both chronic hepatitis B and C are associated with an increased risk of HCC.
Hepatitis A Virus
 HAV is a distinct member of the picornavirus family.
 HAV is a 27- to 32-nm spherical particle with cubic symmetry containing
a linear single-stranded RNA genome with a size of 7.5 kb.
 It is assigned to picornavirus genus, Hepatovirus.
 Only one serotype is known.
 Genomic sequence analysis divided HAV isolates into seven genotypes.
 HAV is stable to treatment with
 20% ether, acid (pH 1.0 for 2 hours)
 Heat (600C for 1 hour).
Hepatitis A Virus
The virus is destroyed by
Autoclaving (1210C for 20 minutes),
Boiling in water for 5 minutes,
Dry heat (1800C for 1 hour),
Ultraviolet irradiation (1 minute at 1.1 watts),
Treatment with formalin (1:4000 for 3 days at 370C), or
Treatment with chlorine (10–15 ppm for 30 minutes).
 Heating food to above 850C for 1 minute and disinfecting surfaces with sodium
hypochlorite (1:100 dilution of chlorine bleach) are necessary to inactivate HAV.
 The relative resistance of HAV to disinfection procedures emphasizes the need for
extra precautions in dealing with hepatitis patients and their products.
Hepatitis A Virus
Pathogenesis
 The transmission of HAV occurs via fecal-oral route, which includes
consumption of contaminated food or water and person to person contact.
 Polymerase chain reaction testing for blood donors is performed as transmission
through blood transfusion is noted on rare occasions.
 The dissemination of the HAV into the liver occurs via the portal vein after the
virus traverses the mucosa of the small intestinal wall.
 The virus particles subsequently replicate and are secreted into the biliary
canaliculi, reaching back to the small intestine through the bile ducts and being re-
excreted in the feces.
 Until the body responds with appropriate immune reaction in antibodies, the HAV
enterohepatic cycle continues.
 Human leukocyte antigen-restricted, HAV-specific CD8+ T lymphocytes and
natural killer cells have been implicated in the damage and destruction of infected
hepatocytes.
Proposed mechanisms of liver injury mediated by HAV.
(A) During HAV infection, the virus activates CD8+ T cells, generating virus-specific
CD8+ T cells. Activated virus-specific CD8 T-cells are differentiated into effector
cytotoxic T lymphocytes that specifically kill virus-infected cells, thus contributing to
liver injury.
(B) In patients with hepatitis A, high levels of IL-15 in the serum activate non-virus-specific
CD8+ T cells, which are capable of lysing both infected and uninfected hepatocytes.
(C) High levels of IL-18 have been detected in both macrophages and hepatocytes in IL-
18BP-deficient patients with fulminant hepatitis A. Due to lack of neutralizing activity
against IL-18, excessive and uncontrolled IL-18 activates NK cells, which subsequently
mediate the lysis of both infected and uninfected hepatocytes.
(D) In patients with severe hepatitis A, HAV seems to activate NKT cells in TIM-1
dependent manner. HAV-infected cells had higher cytotoxic activity in NKT cells carrying
longer form of TIM-1 than in NKT cells harboring the wild type TIM-1, thereby
contributing to liver injury. Apoptosis of HAV-infected hepatocytes mediated by MAVS-
IRF3/IRF7-dependent signaling has also been implicated in liver injury in a murine model
of HAV.
Hepatitis A Virus
Clinical presentation
 Incubation period 2-4 wk.
 Fever, malaise, jaundice most common presenting symptoms.
 Other common symptoms
Weakness,
Fatigue,
Nausea, vomiting,
Abdominal pain,
Arthralgias, Myalgias,
Diarrhea and Anorexia.
 Patients rarely enter a prolonged cholestatic phase through recovery, while relapsing
infections (10%-15% of patients) have been described as well.
Hepatitis A Virus
Clinical presentation
 The symptoms during the relapse are usually less severe than the initial infection.
The spectrum of infections can range from
 Asymptomatic patients without jaundice,
 Symptomatic patients with jaundice,
 Cholestasis with prolonged jaundice, to
 Relapsing infections or,
 Acute liver failure.
 Serum aminotransferases above 1000 U/dL are usually noted, with total
bilirubin typically ≤ 10 mg/dL, and alkaline phosphatase below 400 U/L.
 Usually the serum alanine aminotransferase (ALT) is higher than the aspartate
aminotransferase (AST).
Hepatitis A Virus
Clinical presentation
 In general, older patients are more likely to have severe hepatocellular
derangements, hospital admissions and higher mortality.
 These findings can be attributed to an impaired regeneration capacity of the
liver and a relatively weaker immune system in the older population.
 In addition to old age, higher mortality has been reported in males.
 Old age, underlying liver pathology and chronic viral hepatitis are reported
risk factors for acute liver failure.
 In patients who develop acute liver failure, higher mortality has been
associated with creatinine > 2 mg/dL (strongest predictor) total bilirubin
> 9.6 mg/dL and albumin < 2.5 g/L.
Hepatitis A Virus
Laboratory Diagnosis
 Specific antibodies against HAV (anti-HAV) in the serum can be detected.
 The diagnosis is confirmed by the presence of immunoglobulin (Ig) M anti-HAV.
 The antibodies can be detected at the time of onset of symptoms.
 Serum IgM levels peak during the acute infection and remain positive for up to 4 months
on an average from the onset of symptoms.
 Immunity is usually tested with HAV total antibody to determine HAV natural exposure
or secondary to vaccination.
 The presence of IgM antibodies without any clinical symptoms is indicative of HAV
infection in the past with persistent antibodies, asymptomatic infection or false positive
test.
 Liver biopsy or imaging studies are not required to make a diagnosis.
 If performed, a liver biopsy may show marked portal inflammation with typically a lesser
degree of necrosis, Kupffer cell proliferation, acidophil bodies, or ballooning when
compared to non-HAV viral hepatitis.
Hepatitis A Virus
Management
 No specific treatment is available for HAV and the management is mainly symptomatic.
 The primary focus remains on improving sanitary conditions to minimize the transmission in the
community.
 Historically, immunoglobulins have been used in the prevention of HAV infections.
 With the availability of an effective vaccine, the use of immunoglobulins has been largely
abandoned except in infants below the age of 12 mo.
 Post exposure prophylaxis with hepatitis A vaccine has been approved since 2007 for
immunocompetent patients without chronic liver disease, who are between the ages of 12 mo
and 40 years of age.
 An inactivated HAV vaccine has been licensed in Europe since 1991, while a live attenuated
hepatitis A vaccine has been in use in China since 1992.
 The inactivated virus vaccine was first approved for use in United States in 1995.
 The vaccine has had significant effect on the decrease in HAV infections.
 Long term immune response up to 40 years in noted in over 90% patients who receive both doses
of the 2-vaccine series.
Hepatitis E Virus
 HEV is a single-stranded, nonenveloped RNA virus that is 27 to 34 nm in diameter.
 It is the single member of the genus Hepevirus in the family Hepeviridae.
 HEV has four genotypes in humans and up to 24 subtypes.
 HEV is primarily enterically transmitted.
 Genotypes 1 and 2 are spread by means of fecally contaminated water in endemic
areas and may be spread through blood transfusion, particularly in endemic areas.
 Person-to-person transmission is uncommon but has been documented in households.
 Highest rates of seroprevalence are in Asia, Africa, the Middle East, and Central
America.
 A relatively high seroprevalence (21%) has been found in the United States, apparently
related to infection with attenuated genotypes 3 and 4, which are of limited
pathogenicity and which have been linked to animal-reservoir (predominantly
swine) exposure.
Hepatitis E Virus
 The incubation period of illness is 14 to 60 days (mean, 40 days), and clinical
illness appears to be similar to acute hepatitis from other hepatotropic viruses,
although perhaps more severe than that seen with HAV.
 Fulminant hepatitis can occur, with case-fatality rates of 0.9% to 2.8% in men
and up to 20% in pregnant women, particularly in the third trimester.
 The reason for the markedly increased mortality in pregnant women is unclear but
may be related to increased virus replication observed in pregnancy.
 Most HEV infected patients are either asymptomatic or may develop mild, self-
limited, HAV-like illness.
 The zoonotic genotypes HEV 3 and 4 have been increasingly reported as causes
of chronic hepatitis almost exclusively in those who are immunocompromised.
 Less than 5% of acutely infected HEV patients will progress to acute liver failure
and those patients are more likely to be pregnant, malnourished, or have a
preexisting liver condition.
Hepatitis E Virus
 HEV virions exist in two forms in the infected host, non-enveloped
(neHEV) and quasi-enveloped (eHEV) particles.
 Virions secreted in feces are non-enveloped, spherical particles of
approximately 27–34 nm in diameter.
 However, virions secreted in circulating blood and supernatant of infected
cell cultures are quasi-enveloped as they are covered with a lipid envelope.
 Although neHEV particles are more infectious, eHEV particles are resistant
to antibody neutralization against the viral capsid protein.
 The HEV capsid proteins assemble into virion particles, binds host cells,
and elicit neutralizing antibodies
Hepatitis E Virus
 HEV infection can be diagnosed either indirectly by detecting serum anti-HEV
antibodies or directly by detecting the HEV genome in blood or other bodily
fluids.
 Following an incubation period of 2 to 6 weeks, an initial short lived IgM
response is followed by longer-lasting IgG antibodies.
 Commercial enzyme immunoassays and rapid immunochromatographic kits based
on ORF2/ORF3 peptides or recombinant antigens from HEV1 can detect the
presence of IgM or IgG antibodies induced by the four major genotypes of HEV,
representing a single serotype.
 At clinical presentation, anti-HEV IgM levels had already reached the peak
level, but they remained at relatively high levels for 8 weeks.
 IgM antibodies declined rapidly thereafter, falling below the cut-off level among
most patients after 32 weeks.
 HEV IgG levels were rising when patients presented.
Hepatitis E Virus
 The antibody reached peak levels about 4 weeks after the onset of symptoms and
was maintained at high levels for more than 1 year.
 The presence of anti-HEV IgM is a marker of acute infection.
 “Point-of- care” assays have also been developed to test for anti-HEV IgM
antibodies.
 These immunochromatographic assays are easy to use, give a result within a few
minutes, and are ideally suited to resource-limited settings.
 The presence of anti-HEV IgG alone is a marker of past infection.
 Detection and quantification of HEV RNA in blood and other compartments are
based on real-time PCR with primers targeting conserved regions between HEV
genotypes.
 The loop-mediated isothermal amplification (LAMP) assay, has been
developed for the detection of HEV RNA.
Hepatitis viruses a &amp; e
Hepatitis viruses a &amp; e
Hepatitis viruses a &amp; e
Hepatitis viruses a &amp; e
Hepatitis viruses a &amp; e
Hepatitis viruses a &amp; e

More Related Content

What's hot (20)

Parvovirus b19
Parvovirus b19Parvovirus b19
Parvovirus b19
 
Hepatitis A and E
Hepatitis A and EHepatitis A and E
Hepatitis A and E
 
Viral Hepatitis B, D
Viral Hepatitis B, DViral Hepatitis B, D
Viral Hepatitis B, D
 
Rotavirus
RotavirusRotavirus
Rotavirus
 
adenovirus (2)
adenovirus (2)adenovirus (2)
adenovirus (2)
 
polyoma virus
polyoma viruspolyoma virus
polyoma virus
 
Newer techniques in laboratory diagnosis of malaria
Newer techniques in laboratory diagnosis of malariaNewer techniques in laboratory diagnosis of malaria
Newer techniques in laboratory diagnosis of malaria
 
HEPATITIS "A"
HEPATITIS "A"HEPATITIS "A"
HEPATITIS "A"
 
Rhino virus notes
Rhino virus notesRhino virus notes
Rhino virus notes
 
Hepatitis E infection
Hepatitis E infectionHepatitis E infection
Hepatitis E infection
 
Hepatitis ppt
Hepatitis pptHepatitis ppt
Hepatitis ppt
 
Haemophilus
HaemophilusHaemophilus
Haemophilus
 
Hepatitis A, D, E & G
Hepatitis A, D, E & GHepatitis A, D, E & G
Hepatitis A, D, E & G
 
Bunya virus- Bunyaviridae
Bunya virus- BunyaviridaeBunya virus- Bunyaviridae
Bunya virus- Bunyaviridae
 
Parvovirus-Pathogenicity and Clinical presentation
Parvovirus-Pathogenicity and Clinical presentationParvovirus-Pathogenicity and Clinical presentation
Parvovirus-Pathogenicity and Clinical presentation
 
Adenoviruses
AdenovirusesAdenoviruses
Adenoviruses
 
Malaria
MalariaMalaria
Malaria
 
Orthomyxoviruses
OrthomyxovirusesOrthomyxoviruses
Orthomyxoviruses
 
Hiv
HivHiv
Hiv
 
Pathogenesis Virus
Pathogenesis VirusPathogenesis Virus
Pathogenesis Virus
 

Similar to Hepatitis viruses a &amp; e

Viral Hepatitis disease pathogenesis hbsag
Viral Hepatitis disease pathogenesis hbsagViral Hepatitis disease pathogenesis hbsag
Viral Hepatitis disease pathogenesis hbsagSakshi617058
 
All types of HEPATITIS IN CHILDREN .pptx
All types of HEPATITIS IN CHILDREN .pptxAll types of HEPATITIS IN CHILDREN .pptx
All types of HEPATITIS IN CHILDREN .pptxShibili Abraham
 
syed fazil
syed fazilsyed fazil
syed fazilSyed Ali
 
Acute hepatitis
Acute hepatitis Acute hepatitis
Acute hepatitis Syed Ali
 
Management of patient with hepatic disorder in dental office (hepatitis, alco...
Management of patient with hepatic disorder in dental office (hepatitis, alco...Management of patient with hepatic disorder in dental office (hepatitis, alco...
Management of patient with hepatic disorder in dental office (hepatitis, alco...Shankar Hemam
 
Viral-Hepatitiskhadeejaimad2023ppu8.pptx
Viral-Hepatitiskhadeejaimad2023ppu8.pptxViral-Hepatitiskhadeejaimad2023ppu8.pptx
Viral-Hepatitiskhadeejaimad2023ppu8.pptxkhadeejanofal
 
Liver Disease.ppt
Liver Disease.pptLiver Disease.ppt
Liver Disease.pptShama
 
VIRAL HEPATITIS 4th year 2023.114221321pptx
VIRAL HEPATITIS 4th year 2023.114221321pptxVIRAL HEPATITIS 4th year 2023.114221321pptx
VIRAL HEPATITIS 4th year 2023.114221321pptxMuliChristopherKimeu
 
Viral hepatitis
Viral hepatitisViral hepatitis
Viral hepatitiskemboiarn
 
Hepatitis virus BACKGROUND, PATHOPHYSIOLOGY AND ETIOLOGY
Hepatitis virus  BACKGROUND, PATHOPHYSIOLOGY AND ETIOLOGYHepatitis virus  BACKGROUND, PATHOPHYSIOLOGY AND ETIOLOGY
Hepatitis virus BACKGROUND, PATHOPHYSIOLOGY AND ETIOLOGYDevlop Shrestha
 
Hepatic Disease Keynote
Hepatic Disease KeynoteHepatic Disease Keynote
Hepatic Disease KeynotePatrick Carter
 
Hepatitis.pptx
Hepatitis.pptxHepatitis.pptx
Hepatitis.pptxImtiyaz60
 

Similar to Hepatitis viruses a &amp; e (20)

Viral Hepatitis disease pathogenesis hbsag
Viral Hepatitis disease pathogenesis hbsagViral Hepatitis disease pathogenesis hbsag
Viral Hepatitis disease pathogenesis hbsag
 
Lecture 12.vha vhe
Lecture 12.vha vheLecture 12.vha vhe
Lecture 12.vha vhe
 
All types of HEPATITIS IN CHILDREN .pptx
All types of HEPATITIS IN CHILDREN .pptxAll types of HEPATITIS IN CHILDREN .pptx
All types of HEPATITIS IN CHILDREN .pptx
 
syed fazil
syed fazilsyed fazil
syed fazil
 
Acute hepatitis
Acute hepatitis Acute hepatitis
Acute hepatitis
 
Management of patient with hepatic disorder in dental office (hepatitis, alco...
Management of patient with hepatic disorder in dental office (hepatitis, alco...Management of patient with hepatic disorder in dental office (hepatitis, alco...
Management of patient with hepatic disorder in dental office (hepatitis, alco...
 
Viral hepatitis.ppt
Viral hepatitis.pptViral hepatitis.ppt
Viral hepatitis.ppt
 
Viral hepatitis
Viral hepatitisViral hepatitis
Viral hepatitis
 
Viral-Hepatitiskhadeejaimad2023ppu8.pptx
Viral-Hepatitiskhadeejaimad2023ppu8.pptxViral-Hepatitiskhadeejaimad2023ppu8.pptx
Viral-Hepatitiskhadeejaimad2023ppu8.pptx
 
Hepatic disease
Hepatic diseaseHepatic disease
Hepatic disease
 
Viral hepatitis
Viral hepatitisViral hepatitis
Viral hepatitis
 
Liver Disease.ppt
Liver Disease.pptLiver Disease.ppt
Liver Disease.ppt
 
Hepatic Disease
Hepatic DiseaseHepatic Disease
Hepatic Disease
 
Viral hepatitis
Viral hepatitis Viral hepatitis
Viral hepatitis
 
VIRAL HEPATITIS 4th year 2023.114221321pptx
VIRAL HEPATITIS 4th year 2023.114221321pptxVIRAL HEPATITIS 4th year 2023.114221321pptx
VIRAL HEPATITIS 4th year 2023.114221321pptx
 
Viral hepatitis
Viral hepatitisViral hepatitis
Viral hepatitis
 
Hepatitis virus BACKGROUND, PATHOPHYSIOLOGY AND ETIOLOGY
Hepatitis virus  BACKGROUND, PATHOPHYSIOLOGY AND ETIOLOGYHepatitis virus  BACKGROUND, PATHOPHYSIOLOGY AND ETIOLOGY
Hepatitis virus BACKGROUND, PATHOPHYSIOLOGY AND ETIOLOGY
 
Hepatic Disease Keynote
Hepatic Disease KeynoteHepatic Disease Keynote
Hepatic Disease Keynote
 
Lecture 13.vhbcd
Lecture 13.vhbcdLecture 13.vhbcd
Lecture 13.vhbcd
 
Hepatitis.pptx
Hepatitis.pptxHepatitis.pptx
Hepatitis.pptx
 

More from Suprakash Das

Mycobacterium tuberculosis
Mycobacterium tuberculosisMycobacterium tuberculosis
Mycobacterium tuberculosisSuprakash Das
 
Coccidian parasites -Cyclospora cayetanensis
Coccidian parasites -Cyclospora cayetanensisCoccidian parasites -Cyclospora cayetanensis
Coccidian parasites -Cyclospora cayetanensisSuprakash Das
 
Coccidian parasites- Cryptosporidiosis
Coccidian parasites- CryptosporidiosisCoccidian parasites- Cryptosporidiosis
Coccidian parasites- CryptosporidiosisSuprakash Das
 
Vibrio practical notes
Vibrio practical notesVibrio practical notes
Vibrio practical notesSuprakash Das
 
Leptospira weil's disease
Leptospira weil's diseaseLeptospira weil's disease
Leptospira weil's diseaseSuprakash Das
 
Infective endocarditis
Infective endocarditisInfective endocarditis
Infective endocarditisSuprakash Das
 
Borrelia lyme disease
Borrelia lyme diseaseBorrelia lyme disease
Borrelia lyme diseaseSuprakash Das
 
Laboratory diagnosis of Blood Stream Infections (BSIs)
Laboratory diagnosis of Blood Stream Infections (BSIs)Laboratory diagnosis of Blood Stream Infections (BSIs)
Laboratory diagnosis of Blood Stream Infections (BSIs)Suprakash Das
 
Transplant and Cancer Immunology
Transplant and Cancer ImmunologyTransplant and Cancer Immunology
Transplant and Cancer ImmunologySuprakash Das
 

More from Suprakash Das (20)

Mycobacterium tuberculosis
Mycobacterium tuberculosisMycobacterium tuberculosis
Mycobacterium tuberculosis
 
HIV/AIDS
HIV/AIDSHIV/AIDS
HIV/AIDS
 
Cestodes
CestodesCestodes
Cestodes
 
Coccidian parasites -Cyclospora cayetanensis
Coccidian parasites -Cyclospora cayetanensisCoccidian parasites -Cyclospora cayetanensis
Coccidian parasites -Cyclospora cayetanensis
 
Coccidian parasites- Cryptosporidiosis
Coccidian parasites- CryptosporidiosisCoccidian parasites- Cryptosporidiosis
Coccidian parasites- Cryptosporidiosis
 
E. histolytica
E. histolyticaE. histolytica
E. histolytica
 
Vibrio practical notes
Vibrio practical notesVibrio practical notes
Vibrio practical notes
 
Food poisoning
Food poisoningFood poisoning
Food poisoning
 
Leptospira weil's disease
Leptospira weil's diseaseLeptospira weil's disease
Leptospira weil's disease
 
Infective endocarditis
Infective endocarditisInfective endocarditis
Infective endocarditis
 
Borrelia lyme disease
Borrelia lyme diseaseBorrelia lyme disease
Borrelia lyme disease
 
Leishmaniasis
LeishmaniasisLeishmaniasis
Leishmaniasis
 
Trypanosoma
TrypanosomaTrypanosoma
Trypanosoma
 
Malaria
MalariaMalaria
Malaria
 
Filarisis
FilarisisFilarisis
Filarisis
 
Laboratory diagnosis of Blood Stream Infections (BSIs)
Laboratory diagnosis of Blood Stream Infections (BSIs)Laboratory diagnosis of Blood Stream Infections (BSIs)
Laboratory diagnosis of Blood Stream Infections (BSIs)
 
Transplant and Cancer Immunology
Transplant and Cancer ImmunologyTransplant and Cancer Immunology
Transplant and Cancer Immunology
 
Gram staining
Gram stainingGram staining
Gram staining
 
Gram stain viva 1
Gram stain viva 1Gram stain viva 1
Gram stain viva 1
 
Immune response
Immune responseImmune response
Immune response
 

Recently uploaded

Best Rate (Guwahati ) Call Girls Guwahati ⟟ 8617370543 ⟟ High Class Call Girl...
Best Rate (Guwahati ) Call Girls Guwahati ⟟ 8617370543 ⟟ High Class Call Girl...Best Rate (Guwahati ) Call Girls Guwahati ⟟ 8617370543 ⟟ High Class Call Girl...
Best Rate (Guwahati ) Call Girls Guwahati ⟟ 8617370543 ⟟ High Class Call Girl...Dipal Arora
 
Top Rated Hyderabad Call Girls Erragadda ⟟ 6297143586 ⟟ Call Me For Genuine ...
Top Rated  Hyderabad Call Girls Erragadda ⟟ 6297143586 ⟟ Call Me For Genuine ...Top Rated  Hyderabad Call Girls Erragadda ⟟ 6297143586 ⟟ Call Me For Genuine ...
Top Rated Hyderabad Call Girls Erragadda ⟟ 6297143586 ⟟ Call Me For Genuine ...chandars293
 
Call Girls Kochi Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Kochi Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Kochi Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Kochi Just Call 9907093804 Top Class Call Girl Service AvailableDipal Arora
 
Bangalore Call Girls Nelamangala Number 7001035870 Meetin With Bangalore Esc...
Bangalore Call Girls Nelamangala Number 7001035870  Meetin With Bangalore Esc...Bangalore Call Girls Nelamangala Number 7001035870  Meetin With Bangalore Esc...
Bangalore Call Girls Nelamangala Number 7001035870 Meetin With Bangalore Esc...narwatsonia7
 
Top Rated Bangalore Call Girls Mg Road ⟟ 8250192130 ⟟ Call Me For Genuine Sex...
Top Rated Bangalore Call Girls Mg Road ⟟ 8250192130 ⟟ Call Me For Genuine Sex...Top Rated Bangalore Call Girls Mg Road ⟟ 8250192130 ⟟ Call Me For Genuine Sex...
Top Rated Bangalore Call Girls Mg Road ⟟ 8250192130 ⟟ Call Me For Genuine Sex...narwatsonia7
 
Call Girls Service Jaipur Grishma WhatsApp ❤8445551418 VIP Call Girls Jaipur
Call Girls Service Jaipur Grishma WhatsApp ❤8445551418 VIP Call Girls JaipurCall Girls Service Jaipur Grishma WhatsApp ❤8445551418 VIP Call Girls Jaipur
Call Girls Service Jaipur Grishma WhatsApp ❤8445551418 VIP Call Girls Jaipurparulsinha
 
The Most Attractive Hyderabad Call Girls Kothapet 𖠋 6297143586 𖠋 Will You Mis...
The Most Attractive Hyderabad Call Girls Kothapet 𖠋 6297143586 𖠋 Will You Mis...The Most Attractive Hyderabad Call Girls Kothapet 𖠋 6297143586 𖠋 Will You Mis...
The Most Attractive Hyderabad Call Girls Kothapet 𖠋 6297143586 𖠋 Will You Mis...chandars293
 
(Rocky) Jaipur Call Girl - 09521753030 Escorts Service 50% Off with Cash ON D...
(Rocky) Jaipur Call Girl - 09521753030 Escorts Service 50% Off with Cash ON D...(Rocky) Jaipur Call Girl - 09521753030 Escorts Service 50% Off with Cash ON D...
(Rocky) Jaipur Call Girl - 09521753030 Escorts Service 50% Off with Cash ON D...indiancallgirl4rent
 
Call Girls Bhubaneswar Just Call 9907093804 Top Class Call Girl Service Avail...
Call Girls Bhubaneswar Just Call 9907093804 Top Class Call Girl Service Avail...Call Girls Bhubaneswar Just Call 9907093804 Top Class Call Girl Service Avail...
Call Girls Bhubaneswar Just Call 9907093804 Top Class Call Girl Service Avail...Dipal Arora
 
Call Girls Cuttack Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Cuttack Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Cuttack Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Cuttack Just Call 9907093804 Top Class Call Girl Service AvailableDipal Arora
 
Top Rated Bangalore Call Girls Richmond Circle ⟟ 8250192130 ⟟ Call Me For Gen...
Top Rated Bangalore Call Girls Richmond Circle ⟟ 8250192130 ⟟ Call Me For Gen...Top Rated Bangalore Call Girls Richmond Circle ⟟ 8250192130 ⟟ Call Me For Gen...
Top Rated Bangalore Call Girls Richmond Circle ⟟ 8250192130 ⟟ Call Me For Gen...narwatsonia7
 
Russian Call Girls in Jaipur Riya WhatsApp ❤8445551418 VIP Call Girls Jaipur
Russian Call Girls in Jaipur Riya WhatsApp ❤8445551418 VIP Call Girls JaipurRussian Call Girls in Jaipur Riya WhatsApp ❤8445551418 VIP Call Girls Jaipur
Russian Call Girls in Jaipur Riya WhatsApp ❤8445551418 VIP Call Girls Jaipurparulsinha
 
Call Girls Dehradun Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Dehradun Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Dehradun Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Dehradun Just Call 9907093804 Top Class Call Girl Service AvailableDipal Arora
 
Call Girls Nagpur Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Nagpur Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Nagpur Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Nagpur Just Call 9907093804 Top Class Call Girl Service AvailableDipal Arora
 
Call Girls Ludhiana Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Ludhiana Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Ludhiana Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Ludhiana Just Call 9907093804 Top Class Call Girl Service AvailableDipal Arora
 
Call Girls Ooty Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Ooty Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Ooty Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Ooty Just Call 9907093804 Top Class Call Girl Service AvailableDipal Arora
 
Call Girls Siliguri Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Siliguri Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Siliguri Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Siliguri Just Call 9907093804 Top Class Call Girl Service AvailableDipal Arora
 
VIP Call Girls Tirunelveli Aaradhya 8250192130 Independent Escort Service Tir...
VIP Call Girls Tirunelveli Aaradhya 8250192130 Independent Escort Service Tir...VIP Call Girls Tirunelveli Aaradhya 8250192130 Independent Escort Service Tir...
VIP Call Girls Tirunelveli Aaradhya 8250192130 Independent Escort Service Tir...narwatsonia7
 
Call Girls Varanasi Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Varanasi Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Varanasi Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Varanasi Just Call 9907093804 Top Class Call Girl Service AvailableDipal Arora
 

Recently uploaded (20)

Best Rate (Guwahati ) Call Girls Guwahati ⟟ 8617370543 ⟟ High Class Call Girl...
Best Rate (Guwahati ) Call Girls Guwahati ⟟ 8617370543 ⟟ High Class Call Girl...Best Rate (Guwahati ) Call Girls Guwahati ⟟ 8617370543 ⟟ High Class Call Girl...
Best Rate (Guwahati ) Call Girls Guwahati ⟟ 8617370543 ⟟ High Class Call Girl...
 
Top Rated Hyderabad Call Girls Erragadda ⟟ 6297143586 ⟟ Call Me For Genuine ...
Top Rated  Hyderabad Call Girls Erragadda ⟟ 6297143586 ⟟ Call Me For Genuine ...Top Rated  Hyderabad Call Girls Erragadda ⟟ 6297143586 ⟟ Call Me For Genuine ...
Top Rated Hyderabad Call Girls Erragadda ⟟ 6297143586 ⟟ Call Me For Genuine ...
 
Russian Call Girls in Delhi Tanvi ➡️ 9711199012 💋📞 Independent Escort Service...
Russian Call Girls in Delhi Tanvi ➡️ 9711199012 💋📞 Independent Escort Service...Russian Call Girls in Delhi Tanvi ➡️ 9711199012 💋📞 Independent Escort Service...
Russian Call Girls in Delhi Tanvi ➡️ 9711199012 💋📞 Independent Escort Service...
 
Call Girls Kochi Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Kochi Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Kochi Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Kochi Just Call 9907093804 Top Class Call Girl Service Available
 
Bangalore Call Girls Nelamangala Number 7001035870 Meetin With Bangalore Esc...
Bangalore Call Girls Nelamangala Number 7001035870  Meetin With Bangalore Esc...Bangalore Call Girls Nelamangala Number 7001035870  Meetin With Bangalore Esc...
Bangalore Call Girls Nelamangala Number 7001035870 Meetin With Bangalore Esc...
 
Top Rated Bangalore Call Girls Mg Road ⟟ 8250192130 ⟟ Call Me For Genuine Sex...
Top Rated Bangalore Call Girls Mg Road ⟟ 8250192130 ⟟ Call Me For Genuine Sex...Top Rated Bangalore Call Girls Mg Road ⟟ 8250192130 ⟟ Call Me For Genuine Sex...
Top Rated Bangalore Call Girls Mg Road ⟟ 8250192130 ⟟ Call Me For Genuine Sex...
 
Call Girls Service Jaipur Grishma WhatsApp ❤8445551418 VIP Call Girls Jaipur
Call Girls Service Jaipur Grishma WhatsApp ❤8445551418 VIP Call Girls JaipurCall Girls Service Jaipur Grishma WhatsApp ❤8445551418 VIP Call Girls Jaipur
Call Girls Service Jaipur Grishma WhatsApp ❤8445551418 VIP Call Girls Jaipur
 
The Most Attractive Hyderabad Call Girls Kothapet 𖠋 6297143586 𖠋 Will You Mis...
The Most Attractive Hyderabad Call Girls Kothapet 𖠋 6297143586 𖠋 Will You Mis...The Most Attractive Hyderabad Call Girls Kothapet 𖠋 6297143586 𖠋 Will You Mis...
The Most Attractive Hyderabad Call Girls Kothapet 𖠋 6297143586 𖠋 Will You Mis...
 
(Rocky) Jaipur Call Girl - 09521753030 Escorts Service 50% Off with Cash ON D...
(Rocky) Jaipur Call Girl - 09521753030 Escorts Service 50% Off with Cash ON D...(Rocky) Jaipur Call Girl - 09521753030 Escorts Service 50% Off with Cash ON D...
(Rocky) Jaipur Call Girl - 09521753030 Escorts Service 50% Off with Cash ON D...
 
Call Girls Bhubaneswar Just Call 9907093804 Top Class Call Girl Service Avail...
Call Girls Bhubaneswar Just Call 9907093804 Top Class Call Girl Service Avail...Call Girls Bhubaneswar Just Call 9907093804 Top Class Call Girl Service Avail...
Call Girls Bhubaneswar Just Call 9907093804 Top Class Call Girl Service Avail...
 
Call Girls Cuttack Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Cuttack Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Cuttack Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Cuttack Just Call 9907093804 Top Class Call Girl Service Available
 
Top Rated Bangalore Call Girls Richmond Circle ⟟ 8250192130 ⟟ Call Me For Gen...
Top Rated Bangalore Call Girls Richmond Circle ⟟ 8250192130 ⟟ Call Me For Gen...Top Rated Bangalore Call Girls Richmond Circle ⟟ 8250192130 ⟟ Call Me For Gen...
Top Rated Bangalore Call Girls Richmond Circle ⟟ 8250192130 ⟟ Call Me For Gen...
 
Russian Call Girls in Jaipur Riya WhatsApp ❤8445551418 VIP Call Girls Jaipur
Russian Call Girls in Jaipur Riya WhatsApp ❤8445551418 VIP Call Girls JaipurRussian Call Girls in Jaipur Riya WhatsApp ❤8445551418 VIP Call Girls Jaipur
Russian Call Girls in Jaipur Riya WhatsApp ❤8445551418 VIP Call Girls Jaipur
 
Call Girls Dehradun Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Dehradun Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Dehradun Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Dehradun Just Call 9907093804 Top Class Call Girl Service Available
 
Call Girls Nagpur Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Nagpur Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Nagpur Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Nagpur Just Call 9907093804 Top Class Call Girl Service Available
 
Call Girls Ludhiana Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Ludhiana Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Ludhiana Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Ludhiana Just Call 9907093804 Top Class Call Girl Service Available
 
Call Girls Ooty Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Ooty Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Ooty Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Ooty Just Call 9907093804 Top Class Call Girl Service Available
 
Call Girls Siliguri Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Siliguri Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Siliguri Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Siliguri Just Call 9907093804 Top Class Call Girl Service Available
 
VIP Call Girls Tirunelveli Aaradhya 8250192130 Independent Escort Service Tir...
VIP Call Girls Tirunelveli Aaradhya 8250192130 Independent Escort Service Tir...VIP Call Girls Tirunelveli Aaradhya 8250192130 Independent Escort Service Tir...
VIP Call Girls Tirunelveli Aaradhya 8250192130 Independent Escort Service Tir...
 
Call Girls Varanasi Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Varanasi Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Varanasi Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Varanasi Just Call 9907093804 Top Class Call Girl Service Available
 

Hepatitis viruses a &amp; e

  • 1. Hepatitis Viruses- A & E Dr.Suprakash Das Assist. Prof.
  • 2. INTRODUCTION What Viral Hepatitis is?  Viral hepatitis is an infection that predominantly affects the liver but may also have systemic clinical manifestations.  The vast majority of cases of hepatitis are caused by one of five hepatotropic viruses: Hepatitis A virus (HAV); Hepatitis B virus (HBV); Hepatitis C virus (HCV); Hepatitis D (delta) virus (HDV); and Hepatitis E virus (HEV).  HBV, HCV, and HDV Chronic hepatitis,  HAV Acute Hepatitis.  HEV causes acute hepatitis in normal hosts but can cause protracted and chronic hepatitis in immunosuppressed patients.
  • 3. INTRODUCTION What Viral Hepatitis is?  Liver involvement may also be seen on occasion as part of systemic infections with Herpes simplex virus, Epstein-Barr virus (EBV), Varicella-zoster virus, Enteroviruses, Adenoviruses, Yellow fever virus, Mumps, rubella, and rubeola,  but these viruses do not cause infections that primarily affect the liver.
  • 4. INTRODUCTION What Viral Hepatitis is?  The acute clinical illnesses caused by the five hepatitis viruses (A–E) range from asymptomatic to fulminant and fatal.  The chronic infections caused by HBV, HCV, and HDV range from Subclinical persistent infections to Rapidly progressive chronic liver disease with cirrhosis and Increased risk for hepatocellular carcinoma (HCC).  HEV can also cause protracted and chronic infections in immunosuppressed patients.
  • 5.
  • 6.
  • 7. Acute viral hepatitis Clinical Manifestations  The clinical manifestations of acute viral hepatitis are similar among the five hepatitis viruses.  No clinical features distinguish unequivocally one from the others,  Asymptomatic infections with the hepatitis viruses are approximately 10 to 30 times more common than symptomatic ones.  The incubation periods of hepatitis vary with the individual virus.  “flulike” illness (25% Patients). Symptoms include Malaise, Fatigue, Myalgia, arthralgia, and Headache. Anorexia, nausea, and vomiting may occur, sometimes associated with alterations in olfaction and taste.
  • 8. Acute viral hepatitis Clinical Manifestations  Pharyngitis, coryza, and cough may also be present.  Low-grade fever is common and more frequent in hepatitis A and E.  Dark urine and clay-colored stools may appear, usually 1 to 5 days before the onset of icterus,  A substantial portion of patients never become jaundiced.  With the onset of jaundice, the constitutional symptoms generally abate but may continue during the entire icteric period.  Right upper quadrant tenderness and discomfort are present as the liver enlarges, and  In some patients a cholestatic clinical picture may develop, suggesting extrahepatic biliary obstruction.  Splenomegaly and cervical lymphadenopathy are seen in 10% to 20% of patients.
  • 9. Acute viral hepatitis Clinical Manifestations  As patients recover, constitutional symptoms resolve, but usually some liver enlargement persists, as do elevations of liver biochemical tests.  The duration of the posticteric phase is variable and ranges from 2 to 12 weeks.  It is usually more prolonged in hepatitis B and C.  Complete resolution of clinical and laboratory abnormalities is to be expected 1 to 2 months after the onset of jaundice in acute hepatitis A.  3 to 4 months after the onset of jaundice in 75% of cases of uncomplicated acute hepatitis B or C.  In hepatitis E, acute cases are similar to those in hepatitis A  Protracted infection in hepatitis E Immunosuppressed patients, and severe and fatal infection can occur in pregnant women
  • 10. Acute viral hepatitis Laboratory Features  Serum aspartate aminotransferase (AST) and the alanine aminotransferase (ALT) activities increase to variable levels during the prodromal phase of acute hepatitis and precede elevations in bilirubin.  The magnitude of AST and ALT elevations do not correlate closely with the extent of liver damage.  Peak levels vary from 400 to 4000 international units (IU)/L, and maximums are usually reached when the patient becomes icteric.  Jaundice Billirubin 5 to 20 mg/dL and is usually equally divided between conjugated and unconjugated fractions.  Neutropenia and lymphopenia may be present initially, followed by lymphocytosis with atypical lymphocytes.  A diffuse but modest elevation of the serum globulin fraction is often present, and antibodies to smooth muscle and to other cell constituents can be seen.  Prothrombin times prolonged value may indicate  Severe hepatic synthetic defect,  Severe hepatocellular necrosis  Poor prognosis.
  • 11. Fulminant Hepatitis  Fulminant hepatitis is defined as severe liver failure developing within 8 weeks of the onset of symptoms and is the most feared complication of acute hepatitis.  It is seen primarily with hepatitis B and D  Hepatitis A infection older patients/ chronic hepatitis B or C infection.  Hepatitis B infection of patients with underlying chronic hepatitis C.  Fulminant hepatitis is hardly ever seen in patients with hepatitis C alone.  Hepatitis E may lead to acute liver failure uncommonly in men and in up to 20% of pregnant women.  Hepatitis E is the leading cause in India, and hepatitis B is the leading cause in France and Japan.  Patients with acute fulminant hepatitis usually present with hepatic encephalopathy, which may evolve into a deep coma.  Liver size is reduced,  Bilirubin rises,
  • 12. Fulminant Hepatitis  Prothrombin time is markedly prolonged  Aminotransferase levels drop.  Ascites and peripheral edema are present, consistent with hepatic failure.  Cerebral edema is common, and  Brainstem compression may occur.  Gastrointestinal bleeding, sepsis  Respiratory failure.  Cardiovascular collapse and renal failure are terminal events.  The mortality rate is high (>80% in patients with deep coma), but those who survive have a complete clinical and laboratory recovery.  Liver transplantation, if it can be performed in time, may be lifesaving in such patients.
  • 13. Complications of Acute Hepatitis  Uncommonly, hepatitis A Relapsing hepatitis, occurring weeks to months after apparent recovery from hepatitis A Protracted cholestatic hepatitis persist for up to a year.  During the prodromal phase of hepatitis B, a serum sickness–like syndrome may develop, characterized by arthritis or arthralgias, rash, angioedema, and, rarely, hematuria and proteinuria.  Essential mixed cryoglobulinemia (EMC) and associated lymphoproliferative disorders can complicate chronic (not acute) hepatitis C.  Hepatitis C may be associated with abnormalities in lipoprotein and glucose metabolism.  The risk of chronic infection after acute hepatitis B in otherwise healthy adults is appropriately 1%, whereas the corresponding risk of chronicity after acute hepatitis C is 85% to 90%.  Both chronic hepatitis B and C are associated with an increased risk of HCC.
  • 14. Hepatitis A Virus  HAV is a distinct member of the picornavirus family.  HAV is a 27- to 32-nm spherical particle with cubic symmetry containing a linear single-stranded RNA genome with a size of 7.5 kb.  It is assigned to picornavirus genus, Hepatovirus.  Only one serotype is known.  Genomic sequence analysis divided HAV isolates into seven genotypes.  HAV is stable to treatment with  20% ether, acid (pH 1.0 for 2 hours)  Heat (600C for 1 hour).
  • 15. Hepatitis A Virus The virus is destroyed by Autoclaving (1210C for 20 minutes), Boiling in water for 5 minutes, Dry heat (1800C for 1 hour), Ultraviolet irradiation (1 minute at 1.1 watts), Treatment with formalin (1:4000 for 3 days at 370C), or Treatment with chlorine (10–15 ppm for 30 minutes).  Heating food to above 850C for 1 minute and disinfecting surfaces with sodium hypochlorite (1:100 dilution of chlorine bleach) are necessary to inactivate HAV.  The relative resistance of HAV to disinfection procedures emphasizes the need for extra precautions in dealing with hepatitis patients and their products.
  • 16.
  • 17.
  • 18. Hepatitis A Virus Pathogenesis  The transmission of HAV occurs via fecal-oral route, which includes consumption of contaminated food or water and person to person contact.  Polymerase chain reaction testing for blood donors is performed as transmission through blood transfusion is noted on rare occasions.  The dissemination of the HAV into the liver occurs via the portal vein after the virus traverses the mucosa of the small intestinal wall.  The virus particles subsequently replicate and are secreted into the biliary canaliculi, reaching back to the small intestine through the bile ducts and being re- excreted in the feces.  Until the body responds with appropriate immune reaction in antibodies, the HAV enterohepatic cycle continues.  Human leukocyte antigen-restricted, HAV-specific CD8+ T lymphocytes and natural killer cells have been implicated in the damage and destruction of infected hepatocytes.
  • 19. Proposed mechanisms of liver injury mediated by HAV. (A) During HAV infection, the virus activates CD8+ T cells, generating virus-specific CD8+ T cells. Activated virus-specific CD8 T-cells are differentiated into effector cytotoxic T lymphocytes that specifically kill virus-infected cells, thus contributing to liver injury. (B) In patients with hepatitis A, high levels of IL-15 in the serum activate non-virus-specific CD8+ T cells, which are capable of lysing both infected and uninfected hepatocytes. (C) High levels of IL-18 have been detected in both macrophages and hepatocytes in IL- 18BP-deficient patients with fulminant hepatitis A. Due to lack of neutralizing activity against IL-18, excessive and uncontrolled IL-18 activates NK cells, which subsequently mediate the lysis of both infected and uninfected hepatocytes. (D) In patients with severe hepatitis A, HAV seems to activate NKT cells in TIM-1 dependent manner. HAV-infected cells had higher cytotoxic activity in NKT cells carrying longer form of TIM-1 than in NKT cells harboring the wild type TIM-1, thereby contributing to liver injury. Apoptosis of HAV-infected hepatocytes mediated by MAVS- IRF3/IRF7-dependent signaling has also been implicated in liver injury in a murine model of HAV.
  • 20.
  • 21. Hepatitis A Virus Clinical presentation  Incubation period 2-4 wk.  Fever, malaise, jaundice most common presenting symptoms.  Other common symptoms Weakness, Fatigue, Nausea, vomiting, Abdominal pain, Arthralgias, Myalgias, Diarrhea and Anorexia.  Patients rarely enter a prolonged cholestatic phase through recovery, while relapsing infections (10%-15% of patients) have been described as well.
  • 22. Hepatitis A Virus Clinical presentation  The symptoms during the relapse are usually less severe than the initial infection. The spectrum of infections can range from  Asymptomatic patients without jaundice,  Symptomatic patients with jaundice,  Cholestasis with prolonged jaundice, to  Relapsing infections or,  Acute liver failure.  Serum aminotransferases above 1000 U/dL are usually noted, with total bilirubin typically ≤ 10 mg/dL, and alkaline phosphatase below 400 U/L.  Usually the serum alanine aminotransferase (ALT) is higher than the aspartate aminotransferase (AST).
  • 23. Hepatitis A Virus Clinical presentation  In general, older patients are more likely to have severe hepatocellular derangements, hospital admissions and higher mortality.  These findings can be attributed to an impaired regeneration capacity of the liver and a relatively weaker immune system in the older population.  In addition to old age, higher mortality has been reported in males.  Old age, underlying liver pathology and chronic viral hepatitis are reported risk factors for acute liver failure.  In patients who develop acute liver failure, higher mortality has been associated with creatinine > 2 mg/dL (strongest predictor) total bilirubin > 9.6 mg/dL and albumin < 2.5 g/L.
  • 24.
  • 25. Hepatitis A Virus Laboratory Diagnosis  Specific antibodies against HAV (anti-HAV) in the serum can be detected.  The diagnosis is confirmed by the presence of immunoglobulin (Ig) M anti-HAV.  The antibodies can be detected at the time of onset of symptoms.  Serum IgM levels peak during the acute infection and remain positive for up to 4 months on an average from the onset of symptoms.  Immunity is usually tested with HAV total antibody to determine HAV natural exposure or secondary to vaccination.  The presence of IgM antibodies without any clinical symptoms is indicative of HAV infection in the past with persistent antibodies, asymptomatic infection or false positive test.  Liver biopsy or imaging studies are not required to make a diagnosis.  If performed, a liver biopsy may show marked portal inflammation with typically a lesser degree of necrosis, Kupffer cell proliferation, acidophil bodies, or ballooning when compared to non-HAV viral hepatitis.
  • 26.
  • 27.
  • 28. Hepatitis A Virus Management  No specific treatment is available for HAV and the management is mainly symptomatic.  The primary focus remains on improving sanitary conditions to minimize the transmission in the community.  Historically, immunoglobulins have been used in the prevention of HAV infections.  With the availability of an effective vaccine, the use of immunoglobulins has been largely abandoned except in infants below the age of 12 mo.  Post exposure prophylaxis with hepatitis A vaccine has been approved since 2007 for immunocompetent patients without chronic liver disease, who are between the ages of 12 mo and 40 years of age.  An inactivated HAV vaccine has been licensed in Europe since 1991, while a live attenuated hepatitis A vaccine has been in use in China since 1992.  The inactivated virus vaccine was first approved for use in United States in 1995.  The vaccine has had significant effect on the decrease in HAV infections.  Long term immune response up to 40 years in noted in over 90% patients who receive both doses of the 2-vaccine series.
  • 29.
  • 30.
  • 31.
  • 32. Hepatitis E Virus  HEV is a single-stranded, nonenveloped RNA virus that is 27 to 34 nm in diameter.  It is the single member of the genus Hepevirus in the family Hepeviridae.  HEV has four genotypes in humans and up to 24 subtypes.  HEV is primarily enterically transmitted.  Genotypes 1 and 2 are spread by means of fecally contaminated water in endemic areas and may be spread through blood transfusion, particularly in endemic areas.  Person-to-person transmission is uncommon but has been documented in households.  Highest rates of seroprevalence are in Asia, Africa, the Middle East, and Central America.  A relatively high seroprevalence (21%) has been found in the United States, apparently related to infection with attenuated genotypes 3 and 4, which are of limited pathogenicity and which have been linked to animal-reservoir (predominantly swine) exposure.
  • 33. Hepatitis E Virus  The incubation period of illness is 14 to 60 days (mean, 40 days), and clinical illness appears to be similar to acute hepatitis from other hepatotropic viruses, although perhaps more severe than that seen with HAV.  Fulminant hepatitis can occur, with case-fatality rates of 0.9% to 2.8% in men and up to 20% in pregnant women, particularly in the third trimester.  The reason for the markedly increased mortality in pregnant women is unclear but may be related to increased virus replication observed in pregnancy.  Most HEV infected patients are either asymptomatic or may develop mild, self- limited, HAV-like illness.  The zoonotic genotypes HEV 3 and 4 have been increasingly reported as causes of chronic hepatitis almost exclusively in those who are immunocompromised.  Less than 5% of acutely infected HEV patients will progress to acute liver failure and those patients are more likely to be pregnant, malnourished, or have a preexisting liver condition.
  • 34.
  • 35.
  • 36. Hepatitis E Virus  HEV virions exist in two forms in the infected host, non-enveloped (neHEV) and quasi-enveloped (eHEV) particles.  Virions secreted in feces are non-enveloped, spherical particles of approximately 27–34 nm in diameter.  However, virions secreted in circulating blood and supernatant of infected cell cultures are quasi-enveloped as they are covered with a lipid envelope.  Although neHEV particles are more infectious, eHEV particles are resistant to antibody neutralization against the viral capsid protein.  The HEV capsid proteins assemble into virion particles, binds host cells, and elicit neutralizing antibodies
  • 37.
  • 38.
  • 39.
  • 40.
  • 41. Hepatitis E Virus  HEV infection can be diagnosed either indirectly by detecting serum anti-HEV antibodies or directly by detecting the HEV genome in blood or other bodily fluids.  Following an incubation period of 2 to 6 weeks, an initial short lived IgM response is followed by longer-lasting IgG antibodies.  Commercial enzyme immunoassays and rapid immunochromatographic kits based on ORF2/ORF3 peptides or recombinant antigens from HEV1 can detect the presence of IgM or IgG antibodies induced by the four major genotypes of HEV, representing a single serotype.  At clinical presentation, anti-HEV IgM levels had already reached the peak level, but they remained at relatively high levels for 8 weeks.  IgM antibodies declined rapidly thereafter, falling below the cut-off level among most patients after 32 weeks.  HEV IgG levels were rising when patients presented.
  • 42. Hepatitis E Virus  The antibody reached peak levels about 4 weeks after the onset of symptoms and was maintained at high levels for more than 1 year.  The presence of anti-HEV IgM is a marker of acute infection.  “Point-of- care” assays have also been developed to test for anti-HEV IgM antibodies.  These immunochromatographic assays are easy to use, give a result within a few minutes, and are ideally suited to resource-limited settings.  The presence of anti-HEV IgG alone is a marker of past infection.  Detection and quantification of HEV RNA in blood and other compartments are based on real-time PCR with primers targeting conserved regions between HEV genotypes.  The loop-mediated isothermal amplification (LAMP) assay, has been developed for the detection of HEV RNA.